Exclusive: Onyx provides drug trial data to potential bidders – sources

NEW YORK (Reuters) – Onyx Pharmaceuticals Inc has given potential buyers, including Amgen Inc, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to three people familiar with the matter.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.